Michael Stotz
Impact in
- Oncology top 1%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Co-authors
- Armin Gerger (65 shared papers)Martin Pichler (56 shared papers)Joanna Szkandera (49 shared papers)Tatjana Stojaković (20 shared papers)Gudrun Absenger (21 shared papers)Renate Schaberl-Moser (14 shared papers)H. Samonigg (8 shared papers)Hellmut Samonigg (22 shared papers)
- Journals
- British Journal of Cancer (8 papers)PLoS ONE (5 papers)International Journal of Molecular Sciences (4 papers)Anticancer Research (4 papers)Cancers (3 papers)
- Partner nations
- AustriaUnited StatesSwitzerland
In The Last Decade
Michael Stotz
71 papers receiving 3.2k citations
Michael Stotz's Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 1.9k
- Cancer Research 574
- Internal Medicine 64
- Immunology 294
- Pulmonary and Respiratory Medicine 385
Countries citing papers authored by Michael Stotz
This map shows the geographic impact of Michael Stotz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Stotz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Stotz more than expected).
Fields of papers citing papers by Michael Stotz
This network shows the impact of papers produced by Michael Stotz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Stotz. The network helps show where Michael Stotz may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Stotz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer Hit paper breakdown → | 2013 | 415 |
| 2 | 2017 | 273 | |
| 3 | 2013 | 272 | |
| 4 | 2013 | 183 | |
| 5 | 2013 | 162 | |
| 6 | 2013 | 142 | |
| 7 | 2013 | 128 | |
| 8 | 2014 | 94 | |
| 9 | 2013 | 86 | |
| 10 | 2020 | 81 | |
| 11 | 2013 | 79 | |
| 12 | 2012 | 78 | |
| 13 | 2014 | 68 | |
| 14 | 2016 | 64 | |
| 15 | Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future. | 2015 | 63 |
| 16 | 2016 | 59 | |
| 17 | Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer. | 2013 | 47 |
| 18 | 2014 | 43 | |
| 19 | 2017 | 42 | |
| 20 | 2015 | 42 |
About Michael Stotz
Michael Stotz is a scholar working on Oncology, Surgery, Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 71 papers that have together received 3.2k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (21 papers), Sarcoma Diagnosis and Treatment (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Genetic factors in colorectal cancer (5 papers), Colorectal and Anal Carcinomas (4 papers), Testicular diseases and treatments (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (574 citations), Internal Medicine (64 citations), Immunology (294 citations) and Pulmonary and Respiratory Medicine (385 citations). Michael Stotz has collaborated with scholars based in Austria, United States and Switzerland. Frequent co-authors include Armin Gerger, Martin Pichler, Joanna Szkandera, Tatjana Stojaković, Gudrun Absenger, Renate Schaberl-Moser, H. Samonigg, Hellmut Samonigg, Peter Kornprat and Gerald Höefler. Their work appears in journals such as British Journal of Cancer, PLoS ONE, International Journal of Molecular Sciences, Anticancer Research and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.